Alicia Bagur
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response to Letter to the Editor.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: August 08, 2023
Argentine Guidelines for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Postmenopausal Women and Men Aged 50 Years and Older.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: April 03, 2023
Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Journal: Archives of osteoporosis
Published: August 28, 2018
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: October 20, 2017
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Journal: Lancet (London, England)
Published: May 05, 2017
Prevalence of Osteoporosis in Women in Buenos Aires Based on Bone Mineral Density at the Lumbar Spine and Femur.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
Published: August 04, 2015
Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012
Journal: Medicina
Published: January 22, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026